Effect of Topical Aqueous Suppressants on Intraocular Gas Duration Following Pars Plana Vitrectomy

Inclusion Criteria: * Patients scheduled for pars plana vitrectomy with intraocular gas tamponade with sulfur hexafluoride (e.g., retinal detachment, macular hole, other condition at the discretion of the investigator). * Ability to provide written informed consent and comply with study assessments for the full duration of the study. Exclusion Criteria: * Prior trabeculectomy or tube shunt surgery. * Current use of topical aqueous suppressants or other glaucoma medications. * Aphakia or presence of anterior chamber intraocular lens implant. * Known allergy or contraindication to sulfa or beta-blocker use (e.g., asthma, chronic obstructive pulmonary disease, bradycardia).